Summary
Dr Rasha Al-Lamee is an Clinical Academic Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. She is a British Heart Foundation Intermediate Research Fellow and a Clinical Reader at Imperial College London. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment.
She designed, conducted and led the ORBITA trial and is lead author of the primary publication in The Lancet and 3 secondary publications in Circulation and European Heart Journal. She is the Chief Investigator of the ORBITA-2 trial which was published in New England Journal of Medicine in 2023. At Imperial College is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al-Lamee has over 150 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She is actively involved in the development and recruitment for many multi-centre international clinical trials.
She studied at the University of Oxford and University College London. She completed her training in clinical cardiology on the North West London Cardiology rotation in 2013 and completed her PhD at Imperial College London in 2018.
Dr Al-Lamee has over 16 years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.
She is a deputy editor at EuroIntervention and an associate editor at the European Heart Journal. She is the NIHR CRN North West London Cardiovascular speciality lead and co-head of the cardiovascular theme of the Imperial Biomedical Research Centre. She is Head of Phase 1b and a Deputy Director of Medicine at Imperial College London.
Selected Publications
Journal Articles
Al-Lamee R, Howard JP, Shun-Shin MJ, et al., 2018, Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease., Circulation, Vol:138, Pages:1780-1792
Al-Lamee R, Thompson D, Dehbi H-M, et al., 2018, Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial, The Lancet, Vol:391, ISSN:0140-6736, Pages:31-40